Skip to main content

MoneyWorks4Me

Parenteral Drugs (India) informs about compliance certificate

24 Apr 2021 Evaluate

Parenteral Drugs (India) has informed that it has enclosed the Compliance Certificate pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 for half year ended 31st March, 2021.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.95
Dr. Reddys Labs. 1380.00
Cipla 1394.00
Lupin 1972.50
Zydus Lifesciences 1189.00
View more..